Insulin (human)

Description

The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.

ATC Classification

A10AB01

Insulin (human)

A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AB Insulins and analogues for injection, fast-acting

A10AC01

Insulin (human)

A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AC Insulins and analogues for injection, intermediate-acting

A10AD01

Insulin (human)

A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AD Insulins and analogues for injection, intermediate-acting combined with fast-acting

A10AE01

Insulin (human)

A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AE Insulins and analogues for injection, long-acting

A10AF01

Insulin (human)

A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AF Insulins and analogues for inhalation

Trade names

ACTRAPHANE

Austria Netherlands

ACTRAPID

Australia Austria Cyprus France Netherlands

AFREZZA

United States

ENTUZITY

Canada

HUMINSULIN

Austria

HUMULIN

Australia Canada Cyprus Singapore United Kingdom

HUMULINA

Spain

INSULATARD

Austria Cyprus France Netherlands Singapore

INSUMAN

Austria France Netherlands United Kingdom

MIXTARD

Australia Austria Cyprus France Netherlands

MYXREDLIN

United States

NOVOLIN GE

Canada

PROTAPHANE

Australia Austria Cyprus

UMULINE

France

Product Monographs

ACTRAPID Solution for injection

MPI, EU: SmPC

HUMULIN I Suspension for injection in a vial

MPI, EU: SmPC

Next: Usage >

Insulin (human)

Description

ATC Classification

Trade names

Product Monographs

3D Molecule Structure

Unique Ingredient Identifier (UNII)

CAS Registry Number